Pertussis-induced cough. by Wang, K, Harnden, A

“…Single estimates of anti-pertussis toxin (PT) antibody titres in blood or oral fluid samples are highly specific. …”

Pertussis-induced cough by Wang, K, Harnden, A

“…Single estimates of anti-pertussis toxin (PT) antibody titres in blood or oral fluid samples are highly specific. …”

Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort stud... by Wang, K, Fry, N, Campbell, H, Amirthalingam, G, Harrison, T, Mant, D, Harnden, A

“…MAIN OUTCOME MEASURES: Evidence of recent pertussis infection based on an oral fluid anti-pertussis toxin IgG titre of at least 70 arbitrary units. …”

Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort stud... by Wang, K, Fry, N, Campbell, H, Amirthalingam, G, Harrison, T, Mant, D, Harnden, A

“…<br/> <b>Main outcome measures:</b> Evidence of recent pertussis infection based on an oral fluid anti-pertussis toxin IgG titre of at least 70 arbitrary units. …”

Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial by Wang, K, Taylor, K, Jin, J, Perera, R, Farmer, A, Mant, D, Harnden, A, Birring, S, Fry, N, Harrison, T, Hay, A, Moore, M, Little, P

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. by Wang, K, Birring, S, Taylor, K, Fry, N, Hay, A, Moore, M, Jin, J, Perera, R, Farmer, A, Little, P, Harrison, T, Mant, D, Harnden, A

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial by Wang, K, Birring, S, Taylor, K, Fry, N, Hay, A, Moore, M, Jin, J, Perera, R, Farmer, A, Little, P, Harrison, T, Mant, D, Harnden, A

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”